Developing New Outcome Measures, Functional Biomarkers & Clinical Research Regulatory Frameworks for Disease-Modifying Therapeutics Across Neurodevelopmental & Rare, Genetic CNS Disorders With more clinical data emerging, neurodevelopmental drug development is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers, catapulting this critical field forwards. Join 100+ peers this November at the 2nd Rare […]

The 4th Inflammasome Therapeutics Summit is the only industry-led forum uniting large pharma, biotechs, and academic KOLs, with the common goal of accelerating the practical translation and clinical development of inflammasome-targeted drugs, which are shaking up the immunology R&D landscape. As the space eagerly awaits data readouts from proof-of-concept trials, and with more companies than […]

The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders. With mounting competition […]

Recognized with a Nobel Prize in 2020, CRISPR has opened the floodgates for a new era of gene editing therapies, promising to transform genetic disease treatments. With a well-established early field of genomics research, drug developers and researchers have been busy establishing the next-generation CRISPR toolkit, including Cas nucleases, base and prime editing technologies, and […]

The time has come to remove the pharmaceutical industry’s reliance on archaic off-line testing and embrace the cost and speed-to-market savings of online control and real-time product quality. The PAT market is projected to reach USD 4.96 Billion by 2027, spurred on by the recent ICH Q14/ Q2 (R2) guidelines, there has never been a more […]

Delivering the Next Wave of Gene Therapies to the CNS With systemic toxicity challenges plaguing the AAV field, direct administration for CNS indications creates an ideal target for gene therapy. This is an exciting year for the neurological space with clinical data to show and new biotechs coming out of the woodwork to release the […]

Cell Therapy Analytical Development Summit US is back for its fourth year, taking place in Boston (December 5-7). Join 180+ colleagues from analytical development, process development, quality control and regulatory affairs, to standardize analytical testing and take advantage of unrivalled content across: 3-days 6 deep-dive workshops 2 tracks Seize an unmatched opportunity to delve into cell potency, safety, viability, […]

The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, clinical trial development, and standing out in a crowded market through open discussion and case-study led presentations.   Whether you’re a veteran at commercializing clinically […]

The long-awaited 4th Annual Targeted Radiopharmaceuticals Summit Europe is returning in-person in Amsterdam on December 6-8, 2022! As the only devoted meeting for large pharma, biotech and pioneering academics, this meeting unites key stakeholders under the mutual and ambitious objective of advancing radioligand candidates to commercialisation through rigorous clinical rationale and reliable supply chain design. Download the full Event Guide to learn what the 29+ expert speakers will […]

The field of food allergy therapeutics is continuing to boom as companies flood the news with fresh IND clearances and clinical readouts. The race to market for the next food allergy therapy is well and truly on, but access to funding and large patient cohorts, along with the need for novel IgE biomarkers and better […]

In the context of a need to regroup and accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, blood cancer […]

RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as: Induced Proximity as a new class of "targeted RNA degraders” Next-generation probing and screening technologies to accelerate HIT identification and validation Biophysical, biochemical, and cell-based assay development strategies to identify and […]

Returning for a second year the Synthetic Biology-Based Therapies Summit is the leading industry-defining forum made exclusively for leaders in the synthetic and engineered biology space, focusing on the technical challenges that lie ahead in the path towards commercialization. Download the event guide to find out more Learn from industry trailblazers at Arsenal Biosciences, bit.bio, Moderna, MIT, Novome Bio, Strand Therapeutics, Synlogic and more, to support your […]

The Advanced Wound Care Summit EU is the first industry-led, EU-focused, forum on commercialising innovative wound care products. How will you comply with the EU MDR? What is the best strategy to ensure widespread clinical adoption and reimbursement? What can you do to engage with other wound care companies, for collaboration or acquisition? Expect to hear […]

PURIFY Conclaves are pioneers of dedicated conferences in India that will help stretch possibilities, be it discovery, development or scaleups! The pharmaceutical industry continues to dwell deeper into the growing possibilities for chromatography purification; the PURIFY conclaves touches upon diverse aspects of chromatography purification. The attendees at PURIFY get exposed to a myriad of topics […]

SAE Media Group’s 15th Annual Conference Pre-Filled Syringes and Injectable Drug Devices Europe January 10 - 12 2023 | London, UK http://www.pre-filled-syringes.com/pharmajournalist ------------------------------------------------------------------------- The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to increase patient centricity, aid self-administration and deliver biologics that have large-volumes and novel formulations. […]

11th Annual Pharmaceutical Microbiology Conference  16 - 17 January 2023 London, UK http://www.pharma-microbiology.com/PJwl  Sponsored by: Microgenetics  Co-chairs Di Morris, Clinical Auditor, AstraZeneca and Nigel Cryer, Deputy Director Global Audit, Sanofi  Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy  We are delighted to announce SAE’s 11th Annual Pharmaceutical Microbiology Europe Conference taking place in […]

The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your […]

SAE Media Group’s 2nd Annual Conference Transdermal and Microneedle Drug Delivery January 23 - 24, 2023 | London, UK www.transdermal-microneedle-delivery.co.uk/pharmajournalistel ------------------------------------------------------------------------- SAE Media Group is proud to present the 2nd annual Transdermal and Microneedle Drug Delivery Conference, taking place on the 23rd to 24th January 2023. The 2023 Transdermal and Microneedle Drug Delivery Conference will […]

The 2nd Annual mRNA-Based Therapeutics Summit Europe is the only end-to-end mRNA-dedicated meeting in Europe and the largest gathering for mRNA professionals outside of the United States. Built with biopharmaceutical industry insights, this meeting will unite KOLs from Europe and the rest of the world to delve into the challenges associated with successfully designing and […]

The 6th DDR Inhibitors Summit is taking place in-person for the first time in 3 years in Boston, MA this January 24 – 26, 2023. The DNA damage response inhibitor space only continues to grow, with progress being accelerated by a shift in focus onto next-generation targets like PolQ and WRN, moving forward from monotherapies through combining targets […]

The 2nd HFpEF & HCM Drug Discovery & Development Summit is the definitive industry forum dedicated to propelling drug discovery and development across emerging therapeutics including cell and gene therapies and the implementation of precision medicine. Shake hands with industry pioneers prioritizing the development of therapeutic treatments to complement the new standard of care with […]

Exploit Understanding of TGF-β Biology, Harness Clinically Validated Biomarkers & Advance Safe & Efficacious Clinical Programs for Maximal Therapeutics Benefit in Immuno-Oncology. In the past year alone, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge […]

Over the last few decades, immunotherapy has developed at a rapid rate in the treatment of cancer where neoantigens are the latest breakthrough in tumour immunotherapy. Today, it is still unclear when a cancer vaccine will be made commercially available; what is the latest academic research showing us? What is the industry missing and where […]

SAE Media Group invites you to join the 14th Annual RNA Therapeutics Conference, taking place on 8 and 9 February 2023, in London, UK. Building on the success of previous years, the RNA Therapeutics Conference will bring together industry experts from leading pharma and biotech companies to provide an expert and holistic view on the […]

Introducing the only industry forum exclusively bringing together key decision-makers, within health insurers and providers, who are responsible for payment and revenue integrity, value-based payment, and networking relations. At a time when both payers and providers are evaluating and streamlining internal payment and revenue integrity processes, this networking conference has been established to breakdown silos, […]

6th Annual 3D Cell Culture Conference 8-9 February 2022 London, UK http://www.3D-cellculture.com/PJwl Sponsored: CelVivo, Promega and Systemic Bio Conference Co-chairs: Phillip Hewitt, Global Head of Early Investigative Toxicology, Merck Rhiannon David, Director, Microphysiological Systems, AstraZeneca  Exploring the implementation of complex in-vitro models for drug development Join us in February 2023, as SAE Media Group’s 6th annual […]

The 5th Annual CRISPR AgBio Congress will unite research heads, molecular biologists, regulatory experts, and product developers from large Ag companies, innovative AgBiotechs, academic groups and regulatory bodies to translate share the challenges and opportunities of translating cutting-edge CRISPR technology into a tangible product. If you are working to advance genome-edited crops or plants, this […]

Retinal Vascular Disease Drug Development Summit is an event dedicated to creating a community space dedicated to overcoming the current challenges in drug development for retinal vascular diseases. The management of these diseases has made remarkable advancements in previous years, but the burden on patients remains high, posing a need to develop novel therapeutics and […]

 Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to make CAR and TCR therapies better, and faster. Take advantage of cutting-edge innovation from global biopharma leaders in cell armouring, combination approaches and multiplexing gene engineering to improve cell durability and trafficking […]